Pirtobrutinib(Jaypirca)

C₂₂H₂₁F₄N₅O₃

FOX01 inhibitor program (mantle cell lymphoma)

anti-BCMA CAR T-cell therapy (refractory or relapsed multiple myeloma)

anti-TriPRIL CAR T-cell therapy (relapsed or refractory multiple myeloma)

Anti-CD20 + anti-CD30 CAR T-cell therapy (relapsed/refractory lymphoma)

CAR T-cell therapy (relapsed/refractory B-ALL)

bispecific CD19/CD22 CAR T-cell therapy ( relapsed/refractory B-cell Non-Hodgkin Lymphoma)

Bispecific CD19/CD22 CAR-T Cell Therapy (relapsed/refractory B-cell Lymphoma/ B-ALL/NHL/DLBCL)

anti-CD19 CAR-NK + anti-IL7/anti-CCL19 CAR T-cell therapy (refractory/relapsed B cell lymphoma)

Tisagenlecleucel(Kymriah)

Rx